Garlic and Black Garlic
In many controlled studies, garlic lowered blood pressure, especially as powder and aged extract; black garlic has only been tested in a few small studies.
We evaluated 213 human studies on Garlic and Black Garlic, including 91 randomised controlled trials and 41 meta-analyses or systematic reviews; the controlled studies include 28,976 participants in total. As of 13 October 2026.
1. What Is Garlic and Black Garlic? Occurrence, Origin and Forms
Garlic is the bulb of Allium sativum, a plant in the Amaryllidaceae family. It has long been used as a spice and is a daily ingredient in many kitchens. Black garlic is made from whole garlic bulbs kept warm and humid for weeks; the bulb turns dark and the taste becomes mild and sweet.
Garlic grows in temperate climates and is cultivated worldwide; the cloves of the bulb are the part mainly used. Black garlic is made from fresh bulbs of the same plant and appears as an ingredient in cooking.
Fresh cloves, dried and powdered material, oil macerates and water-alcohol extracts that mature over a longer period (aged garlic extract) are all obtained from the bulbs. Black garlic forms when whole bulbs are kept for weeks at controlled warmth and humidity; browning reactions take place during this time. Studies examine fresh cloves, powder, oil macerates, aged extracts and black garlic, sometimes with a stated content of allicin or S-allyl cysteine.
Forms and Preparations Studied
- Fresh cloves
- Dried garlic powder
- Garlic oil macerate
- Aged garlic extract
- Black garlic
- Preparations standardized to allicin or S-allyl cysteine
Not covered on this page:
- Other alliums such as onion, leek and chives
- Wild garlic (Allium ursinum)
- Combination products in which garlic is only one of several ingredients
2. What Does Garlic and Black Garlic Do? Results by Area
| Area | Result in controlled studies | Strength of evidence | Studies | Participants |
|---|---|---|---|---|
| Blood lipids | mixed | high | 12 meta-analyses · 23 controlled · 21 other | 4,723 |
| Blood pressure | mostly improved | high | 12 meta-analyses · 19 controlled · 12 other | 1,184 |
| Vascular function | mostly improved | high | 4 meta-analyses · 27 controlled · 18 other | 1,108 |
| Immune function | mostly improved | high | 4 meta-analyses · 9 controlled · 5 other | 480 |
| Cancer risk | mostly no difference | moderate | 4 meta-analyses · 6 controlled · 6 other | 13,528 |
| Stomach and gut | mixed | moderate | 1 meta-analyses · 2 controlled · 5 other | 49 |
| Other investigations | mixed | high | 15 meta-analyses · 45 controlled · 49 other | 5,786 |
How to read the table: counted are human studies whose results concern the area. “High” means at least one meta-analysis and two controlled studies showing improvement, or at least three controlled studies of which three quarters show improvement, with at least 300 participants in total. “Moderate” means at least two controlled studies showing improvement, as a majority, or one meta-analysis alongside controlled studies. “Low” means one controlled study showing improvement. Where an area has no controlled study, the strength of evidence is at most “low” (result “reviews only” or “observational data only”). Everything else is “unclear”. A study counts as showing improvement when at least half of its outcomes in this area improved. Reviews of combination products do not count as meta-analyses; results that only describe side effects or shares of users do not count as an effect. The same study is counted only once.
3. What the Studies Show in Detail
Garlic and Black Garlic and Blood Lipids: Human Studies
Several meta-analyses found lower total and LDL cholesterol and lower triglycerides with garlic than with placebo 2421. In type 2 diabetes, especially total cholesterol decreased 14, with aged garlic extract especially LDL cholesterol 15. Garlic powder tablets lowered total and LDL cholesterol and raised HDL cholesterol in a randomized controlled trial 53. In contrast, blood lipids remained without difference from placebo with raw garlic, garlic powder and aged extract in moderately elevated cholesterol 51 and long-term in a large study in China 43. For black garlic, HDL cholesterol increased more than with placebo in a small randomized study, while total and LDL cholesterol as well as triglycerides remained unchanged 120. A low-dose extract from black garlic did not change the usual blood lipid levels 73.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 1 Osadnik et al. 2022 | meta-analysis · 13,062 participants | Garlic as one of several nutraceuticals; vs. Placebo/no intervention | LDL cholesterol: improved (-1.21 [-46.8 mg/dL] to -0.17 [-6.6 mg/dL] mmol/l reduction); Total cholesterol: improved (-1.75 [-67.7 mg/dL] to -0.18 [7 mg/dL] mmol/l reduction) |
| 2 Behrouz et al. 2026 | meta-analysis · 7,137 participants | Garlic preparations, form not specified; not reported; not reported; vs. Control groups of included RCTs | Triglycerides: improved (WMD: -5.82, 95% CI: -8.16 to -3.49 mg/dL); Total cholesterol: improved (WMD: -10.21, 95% CI: -13.69 to -6.74 mg/dL); LDL cholesterol: improved (WMD: -5.90, 95% CI: -10.51 to -1.29 mg/dL) |
| 4 Fu et al. 2023 | meta-analysis · 999 participants | Garlic supplement, oral form not specified; mean dose used as covariate, value not reported; intervention duration used as covariate, value not reported; vs. placebo | triglycerides: improved (SMD (95%CI) = -0.66 (-1.23, -0.09)); total cholesterol: improved (SMD (95%CI) = -0.43 (-0.86, -0.01)); LDL cholesterol: improved (SMD (95%CI) = -0.44(-0.88, -0.01)) |
| 5 Silagy et al. 1994 | meta-analysis · 952 participants | Garlic preparations, including dried garlic powder with standardised allicin; 600-900 mg daily (dried powder); at least four weeks, effect up to six months; vs. placebo or other lipid-lowering agents | Total cholesterol, mean difference in reduction: improved (-0.77 mmol/l (95% CI: -0.65, -0.89 mmol/l)); Triglycerides, reduction by dried powder: improved (0.31 mmol/l (95% CI: -0.14, -0.49)) |
| 7 Wang et al. 2017 | meta-analysis · 768 participants | garlic supplement, allicin-standardized; 0.05 g to 1.5 g allicin daily; 1 to 24 weeks; vs. control group | total cholesterol: improved (SMD = -1.93, 95%CI (-2.98, -0.87)); high density lipoprotein: unclear (SMD = -0.41, 95%CI (-0.83, -0.00)); low density lipoprotein: improved (SMD = -3.47, 95%CI (-5.76, -1.18)) |
| 14 Ebrahimzadeh et al. 2026 | meta-analysis | Garlic supplements (form not specified); longer supplementation associated with improved lipid profiles; vs. placebo/control; garlic alone vs. with oral hypoglycemic agents | Total cholesterol: improved (WMD: -8.26; 95% CI: -14.65 to -1.88); HDL-C: no difference; Triglycerides: no difference |
| 15 Bashiri et al. 2025 | meta-analysis | Aged garlic (AG), various forms; vs. Control group (placebo or usual care) | LDL cholesterol: improved (WMD: -4.41 mg/dL; 95% CI: -8.28 to -0.54); HDL cholesterol: no difference; Total cholesterol: no difference (WMD: -4.74 mg/dL; 95% CI: -9.49 to 0.01) |
| 17 Tang et al. 2025 | meta-analysis | Garlic or garlic products, incl. SAC-standardized preparations; 2.4 mg garlic; SAC optimal 0.5-1.5 mg; 8-week intervention in subgroup analysis; vs. conventional medications or placebo | HDL cholesterol: improved (0.31, 95% CI: 0.03 to 0.59, P = 0.03) |
Further studies in this area: 19 20 21 23 27 33 35 37 43 51 53 58 62 65 67 70 73 75 79 82 85 94 95 98 107 110 116 119 120 126 127 128 139 157 158 163 164 166 167 168 170 173 174 186 195 197 198 199
Garlic and Black Garlic and Blood Pressure: Human Studies
For blood pressure, the most and largest studies are available: several meta-analyses found lower systolic and diastolic values with garlic preparations in adults with hypertension 917183439. Dried garlic powder lowered both values in a meta-analysis 35; for aged garlic extract, the systolic value was reliably lowered, the diastolic only borderline 8. Mean arterial pressure decreased more than with placebo in two randomized controlled trials with garlic powder and freeze-dried garlic extract 61110. Pulse pressure decreased with aged garlic extract 90, but remained unchanged with freeze-dried extract 110. An extract from black garlic with little S-allyl cysteine slightly lowered blood pressure and lowered ACE activity more than placebo in treated grade I hypertension 113. In moderately elevated cholesterol, the diastolic value decreased with such an extract 76. Aged garlic extract lowered systolic but not diastolic pressure in a meta-analysis 15; in treated but uncontrolled hypertension, it only had an effect at higher baseline values 88. In women with polycystic ovary syndrome, a garlic preparation showed only a trend for systolic pressure and no difference for diastolic 70. The evidence is strong and is based mainly on meta-analyses on powder, aged extract and other preparations 83539; black garlic has so far only been tested for blood pressure in two small studies 76113.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 2 Behrouz et al. 2026 | meta-analysis · 7,137 participants | Garlic preparations, form not specified; not reported; not reported; vs. Control groups of included RCTs | Systolic blood pressure: improved (WMD: -3.71, 95% CI: -5.07 to -2.36 mmHg); Diastolic blood pressure: improved (WMD: -1.97, 95% CI: -2.86 to -1.08 mmHg) |
| 4 Fu et al. 2023 | meta-analysis · 999 participants | Garlic supplement, oral form not specified; mean dose used as covariate, value not reported; intervention duration used as covariate, value not reported; vs. placebo | diastolic blood pressure: improved (SMD (95%CI) = -1.33 (-2.14, -0.53)) |
| 8 Saadh et al. 2024 | meta-analysis · 584 participants | Aged garlic extract (AGE), also as tea; effective above 1200 mg/day; vs. Placebo or control | Systolic blood pressure: improved (WMD: -4.03; %95CI: -6.87, -1.20); Diastolic blood pressure: no difference (WMD: -1.44; 95 % CI= -2.87, -0.02) |
| 9 Ried et al. 2020 | meta-analysis · 553 participants | Garlic supplements, including Kyolic aged garlic extract; 3 months of supplementation (Kyolic trials); vs. standard anti-hypertensive medications or control | Systolic blood pressure: improved (8.3±1.9 mmHg); Diastolic blood pressure: improved (5.5±1.9 mmHg) |
| 12 Stabler et al. 2012 | systematic review · 87 participants | Garlic as monotherapy, one trial 200 mg garlic powder; 200 mg garlic powder three times daily (second trial); vs. Placebo, partly added to hydrochlorothiazide-triamterene | Mean supine systolic blood pressure: improved (reduces mean supine systolic blood pressure by 12 mmHg (95% CI 0.56 to 23.44 mmHg, p=0.04)); Mean supine diastolic blood pressure: improved (reduces mean supine diastolic blood pressure by 9 mmHg (95% CI 2.49 to 15.51 mmHg, p=0.007)); Systolic blood pressure (second trial): improved (mean reduction of systolic blood pressure by 10-11 mmHg) |
| 15 Bashiri et al. 2025 | meta-analysis | Aged garlic (AG), various forms; vs. Control group (placebo or usual care) | Systolic blood pressure: improved (WMD: -2.49 mmHg; 95% CI: -4.02 to -0.95); Diastolic blood pressure: no difference |
| 17 Tang et al. 2025 | meta-analysis | Garlic or garlic products, incl. SAC-standardized preparations; 2.4 mg garlic; SAC optimal 0.5-1.5 mg; 8-week intervention in subgroup analysis; vs. conventional medications or placebo | Systolic blood pressure: improved (-4.21, 95% CI: -5.74 to -2.69, P < 0.001); Diastolic blood pressure: improved (-3.13, 95% CI: -4.42 to -1.84, P < 0.001) |
| 18 Ma et al. 2025 | meta-analysis | Garlic extracts (exact form not specified); vs. Placebo | Systolic blood pressure: improved (mean difference: -8.121, 95% confidence interval [CI]: -10.95 to -5.28, P < 0.0001); Diastolic blood pressure: improved (mean difference: -4.256, 95% CI: -5.99 to -2.52, P < 0.0001) |
Further studies in this area: 27 33 34 35 39 60 61 62 65 67 70 72 76 81 82 88 90 96 110 113 115 121 124 128 144 148 152 159 160 161 162 166 168 169 172
Garlic and Black Garlic and Vascular Function: Human Studies
In randomized controlled trials with aged garlic extract, arterial stiffness decreased more than with placebo 747790. Over one year, aged garlic extract slowed the progression of coronary calcification 6098 and reduced low-density, soft plaques in the coronary arteries on CT, but not the total plaque volume 7183. Blood flow in the smallest vessels after brief occlusion improved more with aged extract than with placebo 556396, as did blood flow with an oil extract from purple garlic 84. Endothelium-dependent vasodilation improved with garlic powder in coronary heart disease 119 and with aged extract in a small crossover study 102. Endothelial function remained unchanged, however, with aged extract in type 2 diabetes 97, after a single dose of garlic powder 100, and with an extract from black garlic 113. In a dose study in healthy individuals, aged garlic extract partially inhibited platelet clumping and adhesion, depending on the amount and test condition 93.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 9 Ried et al. 2020 | meta-analysis · 553 participants | Garlic supplements, including Kyolic aged garlic extract; 3 months of supplementation (Kyolic trials); vs. standard anti-hypertensive medications or control | Central blood pressure, pulse pressure, pulse wave velocity, arterial stiffness: improved |
| 20 Josa et al. 2024 | systematic review | Allicin (garlic preparation); vs. Control group (not reported) | cardioprotective effect: improved |
| 23 Gadidala et al. 2023 | systematic review | Garlic powder tablets and aged garlic extract (AGE); vs. randomized controlled trials | Coronary artery calcification (CAC) score: improved (SMD = -1.61; 95% CI = -2.66 to -0.57; p = .003) |
| 33 Varshney et al. 2016 | systematic review | Garlic supplements, most consistently aged garlic extract (AGE); vs. Placebo in double-blind randomized controlled trials | Pulse wave velocity (PWV): improved (favorable effects on CAC, CRP, and PWV); Coronary artery calcium (CAC): improved (favorable effects on CAC, CRP, and PWV) |
| 55 Wlosinska et al. 2019 | randomised controlled · 122 participants | Aged garlic extract (AGE); 2400 mg AGE daily; 1 year; vs. Placebo, double-blinded | Post-occlusive reactive hyperaemia (laser Doppler): improved (102, 64 (174, 15)% change for AGE and 78, 62 (107, 92)% change for the placebo group (F[1, 120] = 5. 95, P < 0.016)) |
| 60 Wlosinska et al. 2020 | randomised controlled · 104 participants | Aged garlic extract (AGE); 2400 mg daily; 1 year; vs. Placebo, double-blind, randomized | Coronary artery calcification (CAC) progression: improved (OR: 2.95 [1.05-8.27]) |
| 63 Lindstedt et al. 2021 | randomised controlled · 93 participants | Aged garlic extract (AGE); 2400 mg AGE daily; 1 year (12 months); vs. Placebo, double-blind randomised | Relative change in post occlusive reactive hyperemia (PORH): improved (21.6% (95% CI 3.2%-40.0%, P < .05)); Cutaneous vascular conductance (CVC) using acetylcholine iontophoresis: improved (21.4% (95% CI 3.4%-39.4%, P < .05)) |
| 67 Ried et al. 2016 | randomised controlled · 88 participants | Aged garlic extract, 1.2 g containing 1.2 mg S-allylcysteine; 1.2 g daily (1.2 mg S-allylcysteine); 12 weeks; vs. Placebo, double-blind randomized | Central hemodynamics and arterial stiffness: unclear |
Further studies in this area: 71 74 75 77 81 83 84 90 93 94 96 97 98 100 102 103 107 110 113 115 118 119 126 130 131 137 144 146 152 157 160 164 167 168 169 170 176 177 188 189 199
Garlic and Black Garlic and Immune Function: Human Studies
Two meta-analyses found lower CRP levels and no difference in IL-6 with garlic; TNF-α decreased overall 2 or with aged garlic extract 29. In randomized controlled trials with aged garlic extract, IL-6 was lower than with placebo 608595, and γδ T and NK cells were more active 56. A systematic review found only one suitable study in which an allicin-containing preparation reduced colds and sick days compared with placebo 11. This is contrasted by results with no difference: with aged garlic extract, the number of colds did not differ from placebo, but they were milder 56. In another study, the proportion of NK cells remained the same 85, in a third, TNF-α and IL-6 showed only trends 90. The overall picture applies predominantly to aged garlic extract; with an extract from black garlic, the inflammatory cytokines did not change 113.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 2 Behrouz et al. 2026 | meta-analysis · 7,137 participants | Garlic preparations, form not specified; not reported; not reported; vs. Control groups of included RCTs | C-reactive protein: improved (WMD: -1.6, 95% CI: -2.38 to -0.82 mg/L); Tumor necrosis factor-α: improved (WMD: -3.94, 95% CI: -5.17 to -2.72 Pg/mL); Interleukin-6: no difference (P ≥ .05) |
| 11 Lissiman et al. 2014 | systematic review · 146 participants | garlic supplement with 180 mg allicin; once daily; 12 weeks; vs. placebo | number of common cold occurrences: improved (24 occurrences of the common cold in the garlic intervention group compared with 65 in the placebo group (P value < 0.001)); days of illness: improved (111 versus 366); days to recovery: no difference (4.63 versus 5.63) |
| 17 Tang et al. 2025 | meta-analysis | Garlic or garlic products, incl. SAC-standardized preparations; 2.4 mg garlic; SAC optimal 0.5-1.5 mg; 8-week intervention in subgroup analysis; vs. conventional medications or placebo | TNF-α: improved (-0.38, 95% CI: -0.72 to -0.04, P = 0.03) |
| 29 Mirzavandi et al. 2020 | meta-analysis | Garlic supplements, including aged garlic extract (AGE); vs. Control group of the included RCTs | C-reactive protein (CRP): improved (P < 0.05); Interleukin-6 (IL-6): no difference (p > 0.05); Tumor necrosis factor-alpha (TNF-α) with aged garlic extract: improved (P < 0.05) |
| 30 Rouf et al. 2020 | systematic review | Garlic and its organosulfur compounds | Antiviral activity and immunomodulation: improved |
| 57 Nantz et al. 2012 | randomised controlled · 120 participants | encapsulated aged garlic extract; 2.56 g/d; 45 days (immune cells), 90 days (cold symptoms); vs. placebo, randomized, double-blind | γδ-T cell proliferation: improved (p = 0.039, n = 56); NK cell proliferation: improved (p = 0.043, n = 56) |
| 60 Wlosinska et al. 2020 | randomised controlled · 104 participants | Aged garlic extract (AGE); 2400 mg daily; 1 year; vs. Placebo, double-blind, randomized | IL-6: improved (OR 2.56 [1.00-6.53]) |
| 85 Xu et al. 2018 | randomised controlled · 51 participants | Aged garlic extract (AGE) or placebo capsules; 3.6 g AGE daily, divided, with food; 6 weeks; vs. Placebo, double-blind, randomized, parallel | Serum IL-6: improved (p = 0.04); Serum TNF-α: improved (p = 0.05); Proportion of γδ-T cells in lymphocytes: improved (p = 0.03) |
Further studies in this area: 89 90 95 101 113 127 140 177 178 191
Garlic and Black Garlic and Cancer Risk: Human Studies
In people with colorectal adenomas, high-dose aged garlic extract slowed their increase in number and size more than a very low dose in a small randomized study 8687; two reviews rely on this study 2640. In a large study in a high-risk region for stomach cancer, garlic did not lower the number of stomach cancer cases, and stomach cancer mortality was only borderline lower 46. Also for the precursors of stomach cancer and in the long-term analysis, garlic brought no confirmed advantage 4748. One review on diet regards garlic consumption as a protective factor against colorectal cancer 36; another describes cancer-inhibiting effects of garlic's sulfur compounds from laboratory, animal, and clinical studies 27. The forms studied range from aged garlic extract to extracts and oil to fresh cloves; it remains open whether the results can be transferred to other population groups and to black garlic, which was not tested in these studies.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 26 Lee et al. 2021 | systematic review | Aged garlic extract (AGE) or garlic as food/supplement; high-dose vs low-dose AGE; 1-year follow-up in the RCT; vs. high-dose AGE vs low-dose AGE; garlic intake vs none | Number and size of colorectal adenomas: improved (P < 0.05); Association of garlic intake with colorectal cancer: unclear |
| 27 De et al. 2021 | systematic review | Garlic and derived organosulfur compounds | Anticancer effects across stages of carcinogenesis: unclear |
| 31 Miraghajani et al. 2018 | systematic review | Aged garlic and its ingredients | Cancer incidence and indices related to malignancy: unclear (inversely associated with cancer) |
| 36 Hou et al. 2013 | systematic review | Garlic (form not specified); vs. Comparison with other diet and lifestyle factors | Protection against colorectal cancer: improved (convincing evidence) |
| 40 Ngo et al. 2007 | systematic review | Raw/cooked garlic, aged garlic extract; vs. Placebo or low vs. high intake | Size and number of colon adenomas: improved (29% reduction); Relative risk of colorectal cancer: improved (30% reduction in relative risk) |
| 45 Guo et al. 2020 | randomised controlled · 3,365 participants | garlic supplementation (form not specified); 7.3 years supplementation, 22.3 years follow-up; vs. placebo, factorial design with vitamin and H. pylori treatment | gastric cancer mortality in never drinkers: unclear (HR, 0.33; 95% CI, 0.15-0.75); gastric cancer mortality in ever drinkers: unclear (HR, 0.92; 95% CI, 0.55-1.54); interaction alcohol and garlic: unclear (P for interaction = .03) |
| 46 Li et al. 2019 | randomised controlled · 3,365 participants | garlic (extract and oil); 7.3 years (1995-2003); vs. placebo in 2×2×2 or 2×2 factorial design | gastric cancer incidence: no difference (0.81, 0.57 to 1.13); gastric cancer mortality: no difference (0.66 (0.43 to 1.00)) |
| 47 Ma et al. 2012 | randomised controlled · 3,365 participants | Garlic extract and garlic oil (oral supplementation); 7.3 years supplementation, 14.7 years follow-up; vs. Placebo (factorial design with H. pylori and vitamin treatment) | Gastric cancer incidence: no difference (non-statistically significant reductions); Gastric cancer mortality: no difference (non-statistically significant reductions) |
Further studies in this area: 48 87 101 152 168 177 181 192
Garlic and Black Garlic, Stomach and Gut: Human Studies
For the stomach and intestines, there is mainly a meta-analysis on allicin from garlic: in addition to standard treatment, it increased the eradication rate of H. pylori and improved ulcer healing 6. In addition, the diversity of the gut flora increased in a randomized controlled trial with aged garlic extract (Kyolic), with more Lactobacillus and Clostridia 90; a review summarizes this finding 9. The strength of evidence is moderate and is based mainly on allicin as an addition to standard treatment and a small study on the gut flora.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 6 Si et al. 2019 | meta-analysis · 867 participants | Allicin from garlic as add-on therapy; vs. Control group without allicin add-on | H. pylori eradication rate: improved (93.33%, 406/435); Ulcer healing rate: improved (86.17%, 349/405); Total remission rate of peptic ulcers: improved (97.16%) |
| 90 Ried et al. 2018 | randomised controlled · 49 participants | Kyolic aged garlic extract (1.2 g, 1.2 mg S-allylcysteine); 1.2 g daily containing 1.2 mg S-allylcysteine; 12 weeks; vs. placebo, double-blind randomized | microbial richness and diversity, Lactobacillus and Clostridia: improved |
| 114 Ettehad-Marvasti et al. 2022 | randomised controlled | Allium sativum powder, 1100 mcg allicin per tablet; two tablets daily; 2 months; vs. placebo | Akkermansia frequency: unclear (decreasing trend); Faecalibacterium abundance: unclear (increasing trend); Bifidobacterium abundance: unclear (increasing trend) |
| 134 Wu et al. 2025 | case-control study · 10,035 participants | Garlic intake (form not specified); vs. Participants without garlic intake or without H. pylori infection | Risk of atrophic gastritis in H. pylori infection: worsened (OR = 1.39, 95% CI: 1.06-1.83); Risk of atrophic gastritis after H. pylori eradication: worsened (OR = 1.16, 95% CI = 1.01-1.32); Risk of atrophic gastritis without H. pylori infection: no difference (OR = 1.14, 95% CI: 0.88-1.46) |
| 149 Martin et al. 2025 | case report · 1 participants | Garlic oil plus milk thistle, bromelain, ginger, passion flower, meditation; 1000 mg garlic oil daily; 29 weeks; vs. no control (case report) | abdominal pain, nausea, eructation, flatulence: improved (alleviated) |
| 177 Xu et al. 2023 | review | Allicin, a thiosulfonate extract from freshly minced garlic | Intestinal flora: improved |
| 188 Ribeiro et al. 2021 | review | Garlic and its organosulfur compounds | Gut dysbiosis: improved |
| 190 Mann et al. 2020 | review | Aged garlic extract (AGE); vs. Mechanical and chemical prevention aids, other natural products | Role in prevention of periodontal disease: unclear |
Garlic and Black Garlic: Further Outcomes in Studies
In non-alcoholic fatty liver, garlic powder improved liver fat more often than placebo and lowered body weight more 5859. In randomized controlled studies, garlic preparations lowered fasting blood sugar or insulin resistance more than placebo 586568; aged extract did not change insulin resistance in a small crossover study 97. In heart failure due to coronary heart disease, heart function, ejection fraction and quality of life improved more with black garlic than with placebo 118. The antioxidant capacity in the blood increased more with black garlic extract 113 and black garlic 118 than with placebo. With garlic tablets, markers of oxidative stress improved only compared with baseline 92. Compared with placebo, catalase and glutathione improved with garlic 69 and malondialdehyde improved with aged extract 94; in two small crossover studies with aged extract, such markers remained unchanged 97102.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 2 Behrouz et al. 2026 | meta-analysis · 7,137 participants | Garlic preparations, form not specified; not reported; not reported; vs. Control groups of included RCTs | Fasting blood glucose: improved (WMD: -2.77, 95% CI: -5.25 to -0.28 mg/dL); Insulin: improved (WMD: -1.74, 95% CI: -2.26 to -1.22 mU/L); HOMA-IR: improved (WMD: -0.37, 95% CI: -0.59 to -0.15) |
| 4 Fu et al. 2023 | meta-analysis · 999 participants | Garlic supplement, oral form not specified; mean dose used as covariate, value not reported; intervention duration used as covariate, value not reported; vs. placebo | body mass index: improved (SMD (95%CI) = -1.10(-1.90, -0.20)); waist circumference: improved (SMD (95%CI) = -0.78(-1.09, -0.47)) |
| 6 Si et al. 2019 | meta-analysis · 867 participants | Allicin from garlic as add-on therapy; vs. Control group without allicin add-on | Side effects |
| 7 Wang et al. 2017 | meta-analysis · 768 participants | garlic supplement, allicin-standardized; 0.05 g to 1.5 g allicin daily; 1 to 24 weeks; vs. control group | fasting blood glucose: improved (SMD = -1.61, 95%CI (-2.89, -0.32)); fructosamine: improved; glycated hemoglobin: improved |
| 9 Ried et al. 2020 | meta-analysis · 553 participants | Garlic supplements, including Kyolic aged garlic extract; 3 months of supplementation (Kyolic trials); vs. standard anti-hypertensive medications or control | Risk of cardiovascular events: unclear (16-40% reduction) |
| 10 Sharifi et al. 2021 | meta-analysis · 266 participants | Garlic supplementation (form not specified); examined in trials with less than 1.5 g per day; vs. Placebo | Serum adiponectin: no difference (WMD, 0.27 Hedges' g; 95% confidence interval [CI], -0.07, 0.62; p = 0.124) |
| 12 Stabler et al. 2012 | systematic review · 87 participants | Garlic as monotherapy, one trial 200 mg garlic powder; 200 mg garlic powder three times daily (second trial); vs. Placebo, partly added to hydrochlorothiazide-triamterene | Cardiovascular morbidity and mortality: unclear |
| 13 Ansary et al. 2020 | review · 83 participants | Garlic, garlic preparations, extracts and bioactive constituents | biomarkers of different diseases: improved |
Further studies in this area: 14 16 17 19 20 23 24 25 28 33 35 38 41 42 49 54 57 58 59 60 61 62 64 65 66 67 68 69 74 75 78 79 80 84 89 91 92 94 96 97 98 99 100 102 104 105 106 108 109 111 112 113 114 117 118 119 122 123 125 127 129 132 133 135 136 138 141 142 143 145 147 148 149 150 151 152 153 154 155 156 158 165 166 167 168 170 171 175 177 178 179 180 182 183 184 185 187 188 193 194 196
4. How Is Garlic and Black Garlic Dosed? Preparation, Dose and Duration in Studies
The most frequently tested were dried garlic powder in tablet form 535961 and aged garlic extract in capsules 7488. Fresh cloves, oil extracts and black garlic have been tested less often as their own preparation 51120.
| Preparation or form | Dose | Duration | Study |
|---|---|---|---|
| aged garlic plus steam-distilled garlic oil | — | 7.3 years | 42 |
| 2 capsules twice daily with 200 mg aged garlic extract and 1 mg garlic oil | 2 capsules twice daily, each containing 200 mg aged garlic extract and 1 mg garlic oil | 7.3 years | 43 |
| capsules with steam-distilled garlic oil and Kyolic aged garlic extract | — | started fall 1995, endpoints 1999 | 44 |
| garlic supplementation (form not specified) | — | 7.3 years supplementation, 22.3 years follow-up | 45 |
| garlic (extract and oil) | — | 7.3 years (1995-2003) | 46 |
| Garlic extract and garlic oil (oral supplementation) | — | 7.3 years supplementation, 14.7 years follow-up | 47 |
| Aged garlic extract plus steam-distilled garlic oil | — | 7.3 years | 48 |
| aged garlic extract (AGE) | three AGE dosage groups, amount not stated | 18 months | 49 |
| Black garlic with or without L. bulgaricus | — | 40 weeks | 50 |
| Raw garlic, powdered garlic supplement, aged garlic extract supplement | Dose equivalent to an average-sized garlic clove (approx. 4 g) per day | 6 months, 6 days per week | 51 |
| Allium sativum powder plus Olea europaea oil | — | 6 months | 52 |
| enteric-coated garlic powder tablet (400 mg garlic, 1 mg allicin) | one tablet twice daily | 6 weeks | 53 |
| Aged Garlic Extract (AGE) | — | four months | 54 |
| Aged garlic extract (AGE) | 2400 mg AGE daily | 1 year | 55 |
| Aged garlic extract (AGE) or placebo | 2.56 g AGE/d | 90 days | 56 |
5. Is Garlic and Black Garlic Safe? Side Effects in Studies
The studies predominantly report good tolerability; several randomized controlled trials observed no serious side effects 58596089. Most commonly mentioned were gastrointestinal complaints, bad breath and occasionally skin rash, without occurring significantly more often than with placebo 111217. One review mentions possible hypoglycemia with simultaneous intake of chlorpropamide and lower warfarin levels 41; with aged garlic extract, the bleeding risk with blood thinners did not increase 67.
| Study | Reported side effects |
|---|---|
| 2 Behrouz et al. 2026 | not reported |
| 3 Long et al. 2023 | Adding polyphenols did not increase adverse events |
| 6 Si et al. 2019 | No significant differences in side effects observed |
| 7 Wang et al. 2017 | no significant difference in complications |
| 9 Ried et al. 2020 | Kyolic considered highly tolerable with high safety profile |
| 11 Lissiman et al. 2014 | rash and odour |
| 12 Stabler et al. 2012 | No serious side effects; 3 cases of slight garlic smell |
| 13 Ansary et al. 2020 | Combination with drugs or food matrices safe |
| 17 Tang et al. 2025 | Gastrointestinal discomfort and bad breath most common, not significantly more frequent |
| 22 Diantini et al. 2023 | Safety of plants confirmed; interactions with remdesivir, favipiravir, lopinavir, ritonavir noted |
| 23 Gadidala et al. 2023 | Garlic described as a safe natural medicine |
| 33 Varshney et al. 2016 | Generally safe; rare adverse reactions documented, causality limited |
6. What Remains Open: Limits of the Evidence
- Many studies tested aged garlic extract or dried powder; there are significantly fewer controlled comparisons for fresh cloves, oil extract and black garlic 51120.
- The studies on black garlic are small and involve few groups, such as people with mild hypertension, elevated cholesterol or heart failure with coronary artery disease 76113118120.
- Individual findings come from mixtures, for example with olive oil, and do not apply to garlic alone 52.
- In a meta-analysis on aged garlic extract, a clear effect on blood pressure only appeared at higher amounts 8.
7. Bottom Line: What Is Established About Garlic and Black Garlic
Garlic is the subject of numerous controlled human studies as a spice and as a tested preparation. The most clearly documented effects are on blood pressure: several meta-analyses found lower systolic and diastolic values 291835. Randomized controlled trials with aged garlic extract also showed lower arterial stiffness 7490. For inflammatory markers and immune cells, studies with aged garlic extract showed lower IL-6 values 608595 and more active NK cells 5689; a meta-analysis found lower CRP and TNF-α values, but no difference in IL-6 29. For blood lipids, garlic in meta-analyses lowered total and LDL cholesterol as well as triglycerides 2421, while large individual studies found no difference 4351. For cancer risk, high-dose aged garlic extract slowed colorectal adenomas in a small study 86; in a large stomach cancer study, the number of cases did not decrease, and mortality was only borderline lower 46.
It should be noted that the results refer to the respective form and preparation studied. Aged garlic extract and dried garlic powder are the most frequently tested, while fresh cloves and oil extracts are rarely studied as their own preparation. Black garlic has so far been tested in a few small randomized trials: an extract slightly lowered blood pressure 76113, and in heart failure, heart function and quality of life improved 118. The usual blood lipid values remained largely unchanged, while HDL cholesterol increased in one study 73120. One review groups garlic with onion and other allium vegetables, so its results do not apply to garlic alone 32.
Frequently Asked Questions
How well has Garlic and Black Garlic been studied in humans?
We evaluated 213 human studies on Garlic and Black Garlic, including 91 randomised controlled trials and 41 meta-analyses or systematic reviews; the controlled studies include 28,976 participants in total. As of 13 October 2026.
Does Garlic and Black Garlic help with blood lipids? What the studies show
Does Garlic and Black Garlic help with blood pressure? What the studies show
Does Garlic and Black Garlic help with vascular function? What the studies show
Does Garlic and Black Garlic help with immune function? What the studies show
Does Garlic and Black Garlic help with cancer risk? What the studies show
Does Garlic and Black Garlic help with stomach and gut? What the studies show
What is black garlic and does it differ from fresh garlic?
Black garlic is made from whole garlic bulbs stored warm and humid for weeks, which makes the bulb dark and the taste mild; the Maillard reaction takes place in the process. Findings on fresh garlic, powder or aged garlic extract therefore cannot be readily transferred to it. In small randomized trials, HDL cholesterol increased with black garlic 120, blood pressure slightly decreased 76113, and in heart failure due to coronary artery disease, heart function and quality of life improved 118.
Which preparations were most frequently tested in the studies?
The most frequently studied were aged garlic extract as capsules and dried garlic powder as tablets 435359617488. Preparations with a stated content of allicin or S-allyl cysteine were also used 6288. Fresh cloves, oil extracts and black garlic were less often studied as their own preparation 51120.
How well was garlic tolerated in the studies?
Does garlic affect blood pressure?
For blood pressure, the most and largest studies are available. Meta-analyses found lower systolic and diastolic values with garlic preparations in adults with hypertension 9171839. Dried garlic powder lowered both values in a meta-analysis 35, aged garlic extract especially the systolic 8. In women with polycystic ovary syndrome, a garlic preparation showed only a trend for systolic pressure and no difference for diastolic 70. An extract from black garlic slightly lowered blood pressure in two small studies 76113.
What do the studies on blood lipids show?
The results are inconsistent. Several meta-analyses found lower levels for total cholesterol, LDL cholesterol and triglycerides 2421; large individual studies saw no difference 4351. For black garlic, HDL cholesterol increased compared with placebo in a randomized controlled trial, while total cholesterol, LDL cholesterol and triglycerides did not change 120.
Sources
- 1Osadnik T, Goławski M, Lewandowski P, Morze J, Osadnik K, Pawlas N et al. · 2022
- 2Behrouz V, Zahroodi M, Clark CCT, Mir E, Atashi N, Rivaz R · 2026
- 3Long Z, Xiang W, He Q, Xiao W, Wei H, Li H et al. · 2023
- 4Fu Z, Lv J, Gao X, Zheng H, Shi S, Xu X et al. · 2023
- 5Silagy C, Neil A · 1994
- 6Si XB, Zhang XM, Wang S, Lan Y, Zhang S, Huo LY · 2019
- 7Wang J, Zhang X, Lan H, Wang W · 2017
- 8Saadh MJ, Kariem M, Shukla M, Ballal S, Kumar A, Chahar M et al. · 2024
- 9
- 10Sharifi S, Talebi S, Nattagh-Eshtivani E, Amiri Y, Askari G · 2021
- 11Lissiman E, Bhasale AL, Cohen M · 2014
- 12Stabler SN, Tejani AM, Huynh F, Fowkes C · 2012
- 13Ansary J, Forbes-Hernández TY, Gil E, Cianciosi D, Zhang J, Elexpuru-Zabaleta M et al. · 2020
- 14Ebrahimzadeh A, Safargar M, Rajabzadeh-Dehkordi M, Nematolahi F, Samadani M, Saeid L et al. · 2026
- 15Bashiri S, TaghipourSheshdeh F, Foshati S, Askarpour M, Ahmadi A, Babajafari S · 2025
- 16A Review of The Efficacy of Complementary and Alternative Medicines in Managing Dermatologic Infectious DiseasesUfomadu P, Gill BJ, Shimizu I, Orengo I, Rosen T · 2025
- 17Tang Y, Lei Y, Xu M, Tu Q, Mao X, Huang N et al. · 2025
- 18
- 19Zhao X, Cheng T, Xia H, Yang Y, Wang S · 2024
- 20
- 21Du Y, Zhou H, Zha W · 2024
- 22Diantini A, Febriyanti RM, Levita J · 2023
- 23Gadidala SK, Johny E, Thomas C, Nadella M, Undela K, Adela R · 2023
- 24Mardi P, Kargar R, Fazeli R, Qorbani M · 2023
- 25Hernández-Cruz EY, Silva-Islas CA, Maldonado PD, Pedraza-Chaverri J, Carballo-Villalobos AI · 2022
- 26Lee J, Zhao N, Fu Z, Choi J, Lee HJ, Chung M · 2021
- 27Anticancer potential of garlic and its bioactive constituents: A systematic and comprehensive reviewDe Greef D, Barton EM, Sandberg EN, Croley CR, Pumarol J, Wong TL et al. · 2021
- 28Letarouilly JG, Sanchez P, Nguyen Y, Sigaux J, Czernichow S, Flipo RM et al. · 2020
- 29Mirzavandi F, Mollahosseini M, Salehi-Abargouei A, Makiabadi E, Mozaffari-Khosravi H · 2020
- 30Rouf R, Uddin SJ, Sarker DK, Islam MT, Ali ES, Shilpi JA et al. · 2020
- 31Miraghajani M, Rafie N, Hajianfar H, Larijani B, Azadbakht L · 2018
- 32Zeng Y, Li Y, Yang J, Pu X, Du J, Yang X et al. · 2017
- 33Varshney R, Budoff MJ · 2016
- 34Wang HP, Yang J, Qin LQ, Yang XJ · 2015
- 35Kwak JS, Kim JY, Paek JE, Lee YJ, Kim HR, Park DS et al. · 2014
- 36Hou N, Huo D, Dignam JJ · 2013
- 37Zeng T, Guo FF, Zhang CL, Song FY, Zhao XL, Xie KQ · 2012
- 38Izzo AA, Ernst E · 2009
- 39Ried K, Frank OR, Stocks NP, Fakler P, Sullivan T · 2008
- 40Ngo SN, Williams DB, Cobiac L, Head RJ · 2007
- 41Izzo AA, Ernst E · 2001
- 42Wang Y, Zhang L, Moslehi R, Ma J, Pan K, Zhou T et al. · 2009
- 43Zhang L, Gail MH, Wang YQ, Brown LM, Pan KF, Ma JL et al. · 2006
- 44Gail MH, You WC, Chang YS, Zhang L, Blot WJ, Brown LM et al. · 1998
- 45Guo Y, Li ZX, Zhang JY, Ma JL, Zhang L, Zhang Y et al. · 2020
- 46Li WQ, Zhang JY, Ma JL, Li ZX, Zhang L, Zhang Y et al. · 2019
- 47Ma JL, Zhang L, Brown LM, Li JY, Shen L, Pan KF et al. · 2012
- 48You WC, Brown LM, Zhang L, Li JY, Jin ML, Chang YS et al. · 2006
- 49Zini A, Zecharyahu L, Gonen H, Vered Y · 2025
- 50Si L, Lin R, Jia Y, Jian W, Yu Q, Wang M et al. · 2019
- 51Gardner CD, Lawson LD, Block E, Chatterjee LM, Kiazand A, Balise RR et al. · 2007
- 52Memon AR, Rajput MA, Rizwan F, Akram M, Rizwan M, Iqbal Z · 2023
- 53Kojuri J, Vosoughi AR, Akrami M · 2007
- 54The Efficacy of Aged Garlic Extract on Gingivitis - A Randomized Clinical TrialZini A, Mann J, Mazor S, Vered Y · 2018
- 55Wlosinska M, Nilsson AC, Hlebowicz J, Malmsjö M, Fakhro M, Lindstedt S · 2019
- 56Percival SS · 2016
- 57Nantz MP, Rowe CA, Muller CE, Creasy RA, Stanilka JM, Percival SS · 2012
- 58Soleimani D, Paknahad Z, Rouhani MH · 2020
- 59Soleimani D, Paknahad Z, Askari G, Iraj B, Feizi A · 2016
- 60Wlosinska M, Nilsson AC, Hlebowicz J, Hauggaard A, Kjellin M, Fakhro M et al. · 2020
- 61Soleimani D, Parisa Moosavian S, Zolfaghari H, Paknahad Z · 2021
- 62Hesari NG, Sadatmahalleh SJ, Mohebbi P, Nasiri M, Khosravi A · 2025
- 63Lindstedt S, Wlosinska M, Nilsson AC, Hlebowicz J, Fakhro M, Sheikh R · 2021
- 64Afarid M, Sadeghi E, Johari M, Namvar E, Sanie-Jahromi F · 2022
- 65Sangouni AA, Alizadeh M, Jamalzehi A, Parastouei K · 2021
- 66Faghihi T, Haghgoo R, Taghizade F, Zareiyan M, Mehran M, Ansari G · 2021
- 67
- 68Zadhoush R, Alavi-Naeini A, Feizi A, Naghshineh E, Ghazvini MR · 2023
- 69Zadhoush R, Alavi-Naeini A, Feizi A, Naghshineh E, Ghazvini MR · 2023
- 70Zadhoush R, Alavi-Naeini A, Feizi A, Naghshineh E, Ghazvini MR · 2021
- 71Shaikh K, Kinninger A, Cherukuri L, Birudaraju D, Nakanishi R, Almeida S et al. · 2020
- 72Ried K, Frank OR, Stocks NP · 2013
- 73Serrano JCE, Castro-Boqué E, García-Carrasco A, Morán-Valero MI, Díez Municio M, Bermúdez-López M et al. · 2026
- 74
- 75Asgharpour M, Khavandegar A, Balaei P, Enayati N, Mardi P, Alirezaei A et al. · 2021
- 76Valls RM, Companys J, Calderón-Pérez L, Salamanca P, Pla-Pagà L, Sandoval-Ramírez BA et al. · 2022
- 77Hamal S, Cherukuri L, Birudaraju D, Matsumoto S, Kinninger A, Chaganti BT et al. · 2020
- 78Hutchins E, Shaikh K, Kinninger A, Cherukuri L, Birudaraju D, Mao SS et al. · 2020
- 79Synergistic effect of Moringa oleifera and Allium sativum on BMI and lipid profile: A randomized controlled trialSarfraz A, Hussain MI, Ibtisam R, Maha A, Asghar S, Zubair K et al. · 2023
- 80Amirsalari S, Behboodi Moghadam Z, Taghizadeh Z, Jafar Abadi MN, Sabaghzadeh Irani P, Goodarzi S et al. · 2021
- 81Gruenwald J, Bongartz U, Bothe G, Uebelhack R · 2020
- 82Mahdavi-Roshan M, Nasrollahzadeh J, Mohammad Zadeh A, Zahedmehr A · 2016
- 83Matsumoto S, Nakanishi R, Li D, Alani A, Rezaeian P, Prabhu S et al. · 2016
- 84Bara-Ledesma N, Jimenez-Esteban J, Fabregate M, Fabregate-Fuente R, Cymberknop LJ, Castillo-Martinez P et al. · 2024
- 85Xu C, Mathews AE, Rodrigues C, Eudy BJ, Rowe CA, O'Donoughue A et al. · 2018
- 86Tanaka S, Haruma K, Yoshihara M, Kajiyama G, Kira K, Amagase H et al. · 2006
- 87Effects of aged garlic extract (AGE) on colorectal adenomas: a double-blinded studyTanaka S, Haruma K, Kunihiro M, Nagata S, Kitadai Y, Manabe N et al. · 2004
- 88Ried K, Frank OR, Stocks NP · 2010
- 89Ishikawa H, Saeki T, Otani T, Suzuki T, Shimozuma K, Nishino H et al. · 2006
- 90
- 91Macan H, Uykimpang R, Alconcel M, Takasu J, Razon R, Amagase H et al. · 2006
- 92Ahmadian F, Mozaffari-Khosravi H, Azaraein MH, Faraji R, Zavar-Reza J · 2017
- 93
- 94Seo DY, Lee SR, Kim HK, Baek YH, Kwak YS, Ko TH et al. · 2012
- 95Wlosinska M, Nilsson AC, Hlebowicz J, Fakhro M, Malmsjö M, Lindstedt S · 2021
- 96Leitão R, de Oliveira GV, Rezende C, Volino-Souza M, Mesquita J, de Carvalho LL et al. · 2022
- 97
- 98Budoff MJ, Takasu J, Flores FR, Niihara Y, Lu B, Lau BH et al. · 2004
- 99Tasnim S, Haque PS, Bari MS, Hossain MM, Islam SM, Shahriar M et al. · 2015
- 100Womack CJ, Lawton DJ, Redmond L, Todd MK, Hargens TA · 2015
- 101Charron CS, Dawson HD, Albaugh GP, Solverson PM, Vinyard BT, Solano-Aguilar GI et al. · 2015
- 102Williams MJ, Sutherland WH, McCormick MP, Yeoman DJ, de Jong SA · 2005
- 103Mateen AA, Rani PU, Naidu MU, Chandrashekar E · 2011
- 104Mohammed Abdul MI, Jiang X, Williams KM, Day RO, Roufogalis BD, Liauw WS et al. · 2008
- 105Tsao JP, Bernard JR, Tu TH, Hsu HC, Chang CC, Liao SF et al. · 2023
- 106Gallicano K, Foster B, Choudhri S · 2003
- 107Phelps S, Harris WS · 1993
- 108Kishan KV, Shah N, Mamatha KV, Sreekumari L, Parikh M · 2025
- 109Shaygannejad V, Mirmosayyeb O, Soltani R, Dinani MS, Shfiee M, Mohsenzadeh A · 2025
- 110Rahmatinia E, Amidi B, Naderi N, Ahmadipour S, Ahmadvand H, Pahlevan-Fallahy MT et al. · 2024
- 111
- 112Taghavi MR, Tavanaei Tamanaei T, Oghazian MB, Tavana E, Mollazadeh S, Niloofar P et al. · 2023
- 113Serrano JCE, Castro-Boqué E, García-Carrasco A, Morán-Valero MI, González-Hedström D, Bermúdez-López M et al. · 2023
- 114Ettehad-Marvasti F, Ejtahed HS, Siadat SD, Soroush AR, Hoseini-Tavassol Z, Hasani-Ranjbar S et al. · 2022
- 115Baik JS, Min JH, Ju SM, Ahn JH, Ko SH, Chon HS et al. · 2022
- 116Analysis of dose and duration dependent effects of Allium sativum Linn and other hypocholesterolemic agents exhibited on dyslipidemia in patients with essential hypertensionAshraf R, Sarwar M, Kamil N, Wahid S, Qureshi A · 2022
- 117Jafari F, Tabarrai M, Abbassian A, Jafari F, Ayati MH · 2021
- 118Liu J, Zhang G, Cong X, Wen C · 2018
- 119Mahdavi-Roshan M, Mirmiran P, Arjmand M, Nasrollahzadeh J · 2017
- 120Jung ES, Park SH, Choi EK, Ryu BH, Park BH, Kim DS et al. · 2014
- 121Nakasone Y, Nakamura Y, Yamamoto T, Yamaguchi H · 2013
- 122Gómez-Arbeláez D, Lahera V, Oubiña P, Valero-Muñoz M, de Las Heras N, Rodríguez Y et al. · 2013
- 123De BK, Dutta D, Pal SK, Gangopadhyay S, Das Baksi S, Pani A · 2010
- 124Bharatbhai PD, B M, Subramanian S · 2026
- 125Yaghoubian H, Niktale H, Yazdi AP, Ghorani V, Rashed MM, Hashemian AM · 2021
- 126Villaño D, Marhuenda J, Arcusa R, Moreno-Rojas JM, Cerdá B, Pereira-Caro G et al. · 2023
- 127Kumar R, Chhatwal S, Arora S, Sharma S, Singh J, Singh N et al. · 2013
- 128Steiner M, Khan AH, Holbert D, Lin RI · 1996
- 129Cheng IS, Tsao JP, Bernard JR, Tsai TW, Chang CC, Liao SF · 2024
- 130Beckert BW, Concannon MJ, Henry SL, Smith DS, Puckett CL · 2007
- 131Weiss N, Ide N, Abahji T, Nill L, Keller C, Hoffmann U · 2006
- 132Pocobelli G, Kristal AR, Patterson RE, Potter JD, Lampe JW, Kolar A et al. · 2010
- 133Shi X, Lv Y, Mao C, Yuan J, Yin Z, Gao X et al. · 2019
- 134Wu J, Zhang J, Jin L, Wei X, Liu Y · 2025
- 135Kantor ED, Lampe JW, Vaughan TL, Peters U, Rehm CD, White E · 2012
- 136Dietary habits and successful aging in Chinese older adults: a cross-sectional analysis of the CLHLSWang Y, Song K, Zhao Z · 2025
- 137Liu Y, Meng G, Zhang Q, Liu L, Wu H, Gu Y et al. · 2021
- 138Du J, Duan Y, Yang L, Cui Y, Liu H · 2025
- 139Stürzebecher PE, Katzmann JL, Gouni-Berthold I, Müller-Kozarez I, Mateev C, Frenzel O et al. · 2025
- 140
- 141
- 142Alzahrani MA, Alsiary KA, Khan MA, Bushnaq A, Alzahrani B, Salama M et al. · 2023
- 143Vahabzadeh M, Balali-Mood M, Banagozar Mohammadi A, Moshiri M · 2021
- 144
- 145Moreno-Ortega A, Pereira-Caro G, Ludwig IA, Motilva MJ, Moreno-Rojas JM · 2023
- 146Effect of garlic (Allium sativum) oil on exercise tolerance in patients with coronary artery diseaseVerma SK, Rajeevan V, Jain P, Bordia A · 2005
- 147Lawson LD, Hunsaker SM · 2018
- 148Houston M, Chen C, D'Adamo CR, Papathanassiu AE, Green SJ · 2023
- 149
- 150
- 151Chaliha D, Vaccarezza M, Lam V, Takechi R, Mamo JC · 2022
- 152Tai X, Luo T, Song K, Zhao H, Chen S, Li H et al. · 2025
- 153Steiner L, Raab A, Feldmann J, Goessler W, Lajin B · 2025
- 154Jain I, Singh V, Jain A, Das S, Das A, Shinde CV et al. · 2025
- 155Bunstine R, Lloyd CM · 2025
- 156Pérez-Torres I, Soto ME, Manzano-Pech L, Díaz-Diaz E, Soria-Castro E, Rubio-Ruíz ME et al. · 2022
- 157
- 158Sun N, Gao Y, Xing Y, Guo M, Xu X, Hu J et al. · 2026
- 159Muhaimin M, Lestari U, Hirzan R, Chaerunisaa AY, Khatib A · 2026
- 160Katsanaki E, Georgiopoulos G, Thymis J, Pavlidis G, Katogiannis K, Nikolaou PE et al. · 2026
- 161
- 162Yanru L, Ulaganathan V, Gunasekaran B, Bhattacharya T · 2025
- 163Liang N, Liu JH, Li Q, He Z, Huang X, Chen ZY · 2025
- 164
- 165Ghasemzadeh Rahbardar M, Boskabady MH · 2025
- 166Mejía Delgado EM, Quiroz-Aldave JE, Durand-Vásquez MDC, Aldave-Pita LN, Fuentes-Mendoza JM, Concepción-Urteaga LA et al. · 2025
- 167Dobre MZ, Virgolici B, Doicin IC, Vîrgolici H, Stanescu-Spinu II · 2025
- 168Fejes R, Bondonno CP, Radavelli-Bagatini S, Kühn T, Wagner KH · 2024
- 169Nyulas KI, Simon-Szabó Z, Pál S, Fodor MA, Dénes L, Cseh MJ et al. · 2024
- 170Lu M, Pan J, Hu Y, Ding L, Li Y, Cui X et al. · 2024
- 171González-Acedo A, Manzano-Moreno FJ, García-Recio E, Ruiz C, Luna-Bertos E, Costela-Ruiz VJ · 2024
- 172Sleiman C, Daou RM, Al Hazzouri A, Hamdan Z, Ghadieh HE, Harbieh B et al. · 2024
- 173Grant JK, Dangl M, Ndumele CE, Michos ED, Martin SS · 2024
- 174von Känel-Cordoba I, Wirnitzer K, Weiss K, Nikolaidis PT, Devrim-Lanpir A, Hill L et al. · 2024
- 175Derosa G, D'Angelo A, Maffioli P · 2024
- 176
- 177Xu S, Liao Y, Wang Q, Liu L, Yang W · 2023
- 178
- 179Mackonochie M, Rodriguez-Mateos A, Mills S, Rolfe V · 2023
- 180Park J, Nurkolis F, Won H, Yang J, Oh D, Jo H et al. · 2023
- 181Zhou Y, Li X, Luo W, Zhu J, Zhao J, Wang M et al. · 2022
- 182Sarecka-Hujar B, Szulc-Musioł B · 2022
- 183Ahangar-Sirous R, Poudineh M, Ansari A, Nili A, Dana SMMA, Nasiri Z et al. · 2022
- 184Hatfield J, Saad S, Housewright C · 2022
- 185Redwood E, Lam V, Takechi R, Kerr DA, Jackaman C, Sharif A et al. · 2022
- 186Cicero AFG, Fogacci F, Stoian AP, Vrablik M, Al Rasadi K, Banach M et al. · 2021
- 187Ahmed T, Wang CK · 2021
- 188Ribeiro M, Alvarenga L, Cardozo LFMF, Chermut TR, Sequeira J, de Souza Gouveia Moreira L et al. · 2021
- 189Zhou DD, Luo M, Shang A, Mao QQ, Li BY, Gan RY et al. · 2021
- 190Mann J, Bernstein Y, Findler M · 2020
- 191Donma MM, Donma O · 2020
- 192Nicastro HL, Ross SA, Milner JA · 2015
- 193Padiya R, Banerjee SK, Banerjee SK · 2013
- 194Choi YH, Chin YW, Kim YG · 2011
- 195Nies LK, Cymbala AA, Kasten SL, Lamprecht DG, Olson KL · 2006
- 196Frank B, Gupta S · 2005
- 197Hermansen K, Dinesen B, Hoie LH, Morgenstern E, Gruenwald J · 2003
- 198Kerckhoffs DA, Brouns F, Hornstra G, Mensink RP · 2002
- 199Kleijnen J, Knipschild P, ter Riet G · 1989
Every statement on this page carries its evidence tier — proven, plausible or hypothesis — and leads to the original work. The decision in the individual case rests with the practitioner; we provide the connections.